For help on how to get the results you want, see our search tips.
2 results
Categories
Human Remove Human filter
Medicine type
Biosimilar Remove Biosimilar filter
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Medicine
Referrals Remove Referrals filter
Referral status
Under evaluation Remove Under evaluation filter
-
List item
Referral: Rubraca (updated)
rucaparib, associated names: Rubraca, Article 20 procedures
Status: Under evaluation, Last updated: 24/06/2022 -
List item
Referral: Janus Kinase inhibitors (JAKi) (updated)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Under evaluation, Last updated: 13/06/2022